Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2095159 Target Snapshot

Serotonin 1 (5-HT1) receptor · PROTEIN FAMILY · Rattus norvegicus

372Compounds
63Assays
16Approved Drugs
372.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P28564. Use UniProt P28564 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28564 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serotonin 1 (5-HT1) receptor as ChEMBL target CHEMBL2095159, mapped to UniProt P28564. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serotonin 1 (5-HT1) receptor
PROTEIN FAMILY · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL2095159
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P28564
5-hydroxytryptamine receptor 1B
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serotonin 1 (5-HT1) receptor is the right protein anchor across sources, using UniProt P28564 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 1B
UniProt AccessionP28564
Component TypeProtein
Sequence Length386 aa

5-hydroxytryptamine receptor 1B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serotonin 1 (5-HT1) receptor, mapped to UniProt P28564. ChEMBL maps the protein component as 5-hydroxytryptamine receptor 1B. Sequence length is 386 aa.

Mapped IDP28564
Review nameSerotonin 1 (5-HT1) receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

16
Approved
2
Phase III
11
Phase II
Assay Mix

Activity Type Distribution

IC50209.0
KI155.0
KD8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL300585 9.3 IC50 0.5 Preclinical
CHEMBL57483 9.0 IC50 1.0 Preclinical
CHEMBL294425 8.96 IC50 1.1 Preclinical
CHEMBL274728 8.92 IC50 1.2 Preclinical
CHEMBL57506 8.82 IC50 1.5 Preclinical
CHEMBL60640 8.74 IC50 1.8 Preclinical
CHEMBL18785 8.7 Ki 2.0 Preclinical
CHEMBL39 8.7 Ki 2.0 Clinical
CHEMBL8165 8.7 Ki 2.0 Preclinical
CHEMBL299917 8.68 IC50 2.1 Preclinical
Distribution

pChEMBL Value Distribution

36
5.0
42
5.5
47
6.0
33
6.5
35
7.0
38
7.5
22
8.0
12
8.5
2
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

GEPIRONE HYDROCHLORIDE
CHEMBL1204187
Approved 2023
TAMSULOSIN
CHEMBL836
Approved 1997
RISPERIDONE
CHEMBL85
Approved 1993
CLOZAPINE
CHEMBL42
Approved 1989
FLUOXETINE
CHEMBL41
Approved 1987
BUSPIRONE HYDROCHLORIDE
CHEMBL1200399
Approved 1986
PINDOLOL
CHEMBL500
Approved 1982
METHYSERGIDE
CHEMBL1065
Approved 1962
Assay Landscape

Assay Landscape

63
Total Assays
267
Tested Compounds
1
Assay Types
Binding — 63 assays, 267 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 27 80 6.7
protein format 24 42 6.8
cell membrane format 6 38 7.9
assay format 5 48 6.3
subcellular format 1 59 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine